E-LIB Suche - Ergebnisse für: Moguem Soubgui, Arlette Flore - Sprache DE

Sortierung: Relevanz

Sortierung: Jahr

1

Serological surveillance reveals a high exposure to SARS-Co..:

Moguem Soubgui, Arlette Flore ; Ndeme Mboussi, Wilfred Steve ; Kojom Foko, Loick Pradel...
PLOS Global Public Health. 4 (2024) 2 - p. e0002380 , 2024

Link: https://doi.org/10.1371/..

2

Exploring demographical, clinical, and dietary determinants..:

Moguem Soubgui, Arlette Flore ; Ndeme Mboussi, Wilfried Steve ; Kojom Foko, Loick Pradel..
Heliyon. 10 (2024) 3 - p. e24926 , 2024

Link: https://doi.org/10.1016/..

3

Confounding role of comorbidities and COVID-19 vaccination ..:

Moguem Soubgui, Arlette Flore ; Kojom Foko, Loick Pradel ; Embolo Enyegue, Elisée Libert...
IJID Regions. 8 (2023) - p. 129-136 , 2023

Link: https://doi.org/10.1016/..

4

Epidemiological situation of SARS-CoV-2 infection in Douala..:

Moguem Soubgui, Arlette Flore ; Embolo Enyegue, Elisee Libert ; Kojom Foko, Loick Pradel...
Acta Tropica. 241 (2023) - p. 106864 , 2023

Link: https://doi.org/10.1016/..

5

Crude SARS-CoV-2 seroprevalence profile by months and healt..:

Arlette Flore Moguem Soubgui ; Wilfred Steve Ndeme Mboussi ; Loick Pradel Kojom Foko..
doi:10.1371/journal.pgph.0002380.s003. , 2024

Link: https://doi.org/10.1371/..

6

Crude SARS-CoV-2 seroprevalence profile by clinical symptom:

Arlette Flore Moguem Soubgui ; Wilfred Steve Ndeme Mboussi ; Loick Pradel Kojom Foko..
doi:10.1371/journal.pgph.0002380.s004. , 2024

Link: https://doi.org/10.1371/..

7

Flow diagram of the study:

Arlette Flore Moguem Soubgui ; Wilfred Steve Ndeme Mboussi ; Loick Pradel Kojom Foko..
doi:10.1371/journal.pgph.0002380.g001. , 2024

Link: https://doi.org/10.1371/..

8

Testing SARS-CoV-2 immune response parameters (IgM, IgG, CD..:

Arlette Flore Moguem Soubgui ; Wilfred Steve Ndeme Mboussi ; Loick Pradel Kojom Foko..
doi:10.1371/journal.pgph.0002380.s002. , 2024

Link: https://doi.org/10.1371/..

9

Overall variation of CD4+ (A, D), IFN-γ (B, E) and IL-6 (C,..:

Arlette Flore Moguem Soubgui ; Wilfred Steve Ndeme Mboussi ; Loick Pradel Kojom Foko..
doi:10.1371/journal.pgph.0002380.g005. , 2024

Link: https://doi.org/10.1371/..

10

Clinical value of symptoms for prognostic of IgM seropositi..:

Arlette Flore Moguem Soubgui ; Wilfred Steve Ndeme Mboussi ; Loick Pradel Kojom Foko..
doi:10.1371/journal.pgph.0002380.s005. , 2024

Link: https://doi.org/10.1371/..

11

Fig 2 -:

Arlette Flore Moguem Soubgui ; Wilfred Steve Ndeme Mboussi ; Loick Pradel Kojom Foko..
doi:10.1371/journal.pgph.0002380.g002. , 2024

Link: https://doi.org/10.1371/..

12

Univariate logistic regression between SARS-CoV-2 antibodie..:

Arlette Flore Moguem Soubgui ; Wilfred Steve Ndeme Mboussi ; Loick Pradel Kojom Foko..
doi:10.1371/journal.pgph.0002380.t002. , 2024

Link: https://doi.org/10.1371/..

13

Predictors of the presence of anti-SARS-CoV-2 antibodies am..:

Arlette Flore Moguem Soubgui ; Wilfred Steve Ndeme Mboussi ; Loick Pradel Kojom Foko..
doi:10.1371/journal.pgph.0002380.t004. , 2024

Link: https://doi.org/10.1371/..

14

Crude prevalence of SARS–CoV–2 antibodies by study sites:

Arlette Flore Moguem Soubgui ; Wilfred Steve Ndeme Mboussi ; Loick Pradel Kojom Foko..
doi:10.1371/journal.pgph.0002380.g003. , 2024

Link: https://doi.org/10.1371/..

15

Univariate logistic regression between SARS-CoV-2 antibodie..:

Arlette Flore Moguem Soubgui ; Wilfred Steve Ndeme Mboussi ; Loick Pradel Kojom Foko..
doi:10.1371/journal.pgph.0002380.t002. , 2024

Link: https://doi.org/10.1371/..

1-15